Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.7.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Cash flows from operating activities    
Net income (loss) $ 7,242 $ 3,197
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 2,745 1,786
Equity-based compensation 2,569 2,008
Equity method investments (1,118) 220
Gain on sale of financing receivables and investments (3,923) (4,314)
Changes in financing receivables held-for-sale   5,382
Changes in accounts payable and accrued expenses (742) 2,776
Other (1,529) (1,189)
Net cash provided by operating activities 5,244 9,866
Cash flows from investing activities    
Purchases of financing receivables (35,505) (76,142)
Principal collections from financing receivables 32,222 8,662
Proceeds from sales of financing receivables 12,084 29,127
Purchases of investments (10,106) (12,864)
Principal collections from investments 48 677
Purchases of real estate (106,854) (7,327)
Equity method investments (97,656) (1,622)
Equity method distributions received 13,847 15,991
Other (29,905) (484)
Net cash used in investing activities (221,825) (43,982)
Cash flows from financing activities    
Proceeds from credit facilities 235,612 90,800
Principal payments on credit facilities (112,228) (16,328)
Proceeds from nonrecourse debt 114,424  
Principal payments on nonrecourse debt (15,803) (18,509)
Payments on deferred funding obligations (30,369) (25,594)
Net proceeds of common stock issuances 67,840  
Payments of dividends and distributions (15,850) (11,566)
Other (3,379) (682)
Net cash provided by financing activities 240,247 18,121
Increase (decrease) in cash, cash equivalents, and restricted cash 23,666 (15,995)
Cash, cash equivalents, and restricted cash at beginning of period 59,144 79,216
Cash, cash equivalents, and restricted cash at end of period 82,810 63,221
Interest paid 11,526 9,319
Non-cash changes in deferred funding obligations 33,822 (20,364)
Non-cash changes in financing receivables and investments $ (33,822) $ 20,862